1. Overbeck I, Bartels M, Decker O, et al. Changes in quality of life after renal transplantation. Transplant Proc 2005; 37: 1618-21.
2.
Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-30.
3.
Peters TG, Spinola KN, West JC, et al. Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 2004; 78: 537-43.
4.
Ho CH, Sood T, Zito PM. Androgenetic alopecia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 7, 2024.
5.
Hughes EC, Syed HA, Saleh D. Telogen effluvium. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2024.
6.
Saleh D, Nassereddin A, Saleh HM, et al. Anagen effluvium. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 30, 2024.
7.
Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc 2013; 16: S13-5.
8.
Tricot L, Lebbé C, Pillebout E, et al. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation 2005; 80: 1546e9.
9.
Imko-Walczuk B, Okuniewska A, Prêdota-G³owacka A, et al. Benign cutaneous disease among Polish renal transplant recipients. Transplant Proc 2016; 48: 1660-6.
10.
Bencini PL, Montagnino G, Sala F, et al. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 1986; 172: 24-30.
11.
Busque S, Demers P, St-Louis G, et al. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplant Proc 1998; 30: 1247-8.
12.
Prakash J, Singh S, Prashant GK, et al. Mucocutaneous lesions in transplant recipient in a tropical country. Transplant Proc 2004; 36: 2162-4.
13.
Videla CO. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. Transplant Proc 2009; 41: 2659-63.
14.
Rostaing L, Sánchez-Fructuoso A, Franco A, et al. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study. Transpl Int 2012; 25: 391-400.
15.
Usuki S, Uno S, Sugamori H, et al. Safety and effectiveness of conversion from cyclosporine to once-daily prolonged-release tacrolimus in stable kidney transplant patients: a multicenter observational study in Japan. Transplant Proc 2018; 50: 3266-74.
16.
Ringdén O, Bergstrand A, Collste H, et al. Immunosuppression by cyclosporin A in human renal transplant recipients. Scand J Urol Nephrol Suppl 1981; 64: 220-9.
17.
Hequet O, Vocanson M, Saint-Mezard P, et al. CD4 T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant 2004; 4: 872-8.
18.
Shapiro R, Fung JJ, Jain AB, et al. The side effects of FK 506 in humans. Transplant Proc 1990; 22: 35-6.
19.
Peters TG, Spinola KN, West JC, et al. Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 2004; 78: 537-43.
20.
Kim HC, Hwang EA, Han SY, et al. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Transplant Proc 2004; 36: 2082-3.
21.
Meera M, Manikandan S, Parameswaran S. Adverse effects of tacrolimus and its associated risk factors in renal transplant recipients. Exp Clin Transplant 2023; 21: 22-7.
22.
Lee EC, Kim SH, Park SJ. Safety and efficacy of once-daily prolonged-release tacrolimus in living donor liver transplantation: an open-label, prospective, single-arm, phase 4 study. Ann Transplant 2018; 23: 713-20.
23.
Alatas FS, Matsuura T, Yoshimaru K, et al.. Alopecia in children following living related liver transplantation. Transplant Proc 2021; 53: 228-32.
24.
Talbot T, Rix D, Abusin K, et al. Alopecia as a consequences of tacrolimus therapy in renal transplantation. Transplantation 1997; 64: 1631e2.
25.
Hawkshaw NJ, Haslam IS, Ansell DM, et al. Re-evaluating cyclosporine a as a hair growth-promoting agent in human scalp hair follicles. J Invest Dermatol 2015; 135: 2129-32.
26.
Ponticelli C, Bencini PL. Nonneoplastic mucocutaneous lesions in organ transplant recipients. Transpl Int 2011; 24: 1041-50.
27.
Higgins RM, Hart P, Lam FT, et al. Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. Transplantation 2000; 70: 199-202.
28.
Mohsin N, Pakkyara A, Budruddin M, et al. Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? Transplant Proc 2005; 37: 2911-2.
29.
Phillips MA, Graves JE, Nunley JR. Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. J Am Acad Dermatol 2005; 53 (5 Suppl 1): S252-5.
30.
Mártinez JM, Pulido LB, Bellido CB, et al. Rescue immunosuppression with mammalian target of rapamycin inhibitor drugs in liver transplantation. Transplant Proc 2010; 42: 641-3.
31.
Murray JE, Merrill JP, Harrison JH, et al. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315-23.
32.
Shah S, Verma P. Overview of pregnancy in renal transplant patients. Int J Nephrol 2016; 2016: 4539342.
33.
Saida K, Kamei K, Ogura M, et al. Azathioprine-induced agranulocytosis and severe alopecia after kidney transplantation associated with a NUDT15 polymorphism: a case report. Transplant Proc 2018; 50: 3925-7.
34.
Wagoner LE, Olsen SL, Bristow MR, et al. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation 1993; 56: 1415-8.
35.
Palmer SC, Tunnicliffe DJ, Singh-Grewal D, et al. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: a network meta-analysis of randomized trials. Am J Kidney Dis 2017; 70: 324-36.
36.
Castello M, Gregorini M, Rampino T, et al. A retrospective analysis of dermatological lesions in kidney transplant patients. Indian J Med Res 2013; 137: 1188-92.
37.
Miotto IZ, Souza BCE, Tyring SK, et al. Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients. Transpl Immunol 2021; 64: 101355.
38.
Matas AJ, Halbert RJ, Barr ML, et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant 2002; 16: 113-21.
39.
Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol 2013; 2013: 348546.